As­traZeneca un­veils what it calls ‘prac­tice-chang­ing’ Imfinzi da­ta in blad­der can­cer

BARCELONA — In a re­sult that’s like­ly to change how some blad­der can­cer pa­tients get care, As­traZeneca said that its drug Imfinzi boost­ed pa­tient sur­vival along­side …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER